Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-029714
Filing Date
2010-05-27
Accepted
2010-05-27 12:56:40
Documents
2
Period of Report
2010-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd277097.html 3  
1 FORM 3 rrd277097.xml 3 2267
2 POA rrd248272_280187.htm EX-24. 3353
  Complete submission text file 0001181431-10-029714.txt   7491
Mailing Address 3116 BRAEMAR DRIVE WILMINGTON NC 28401
Business Address
COVINGTON PAUL S (Reporting) CIK: 0001181153 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34641 | Film No.: 10861668

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-380-2000
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations